231 related articles for article (PubMed ID: 12804980)
1. Fibrodysplasia ossificans progressiva.
Blaszczyk M; Majewski S; Brzezinska-Wcislo L; Jablonska S
Eur J Dermatol; 2003; 13(3):234-7. PubMed ID: 12804980
[TBL] [Abstract][Full Text] [Related]
2. Exoneration of NF-kappaB dysregulation in fibrodysplasia ossificans progressiva.
Ahn J; Feldman G; Terry L; Shore EM; Kaplan FS
Clin Orthop Relat Res; 2003 Jan; (406):205-13. PubMed ID: 12579020
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva.
Shafritz AB; Shore EM; Gannon FH; Zasloff MA; Taub R; Muenke M; Kaplan FS
N Engl J Med; 1996 Aug; 335(8):555-61. PubMed ID: 8678932
[TBL] [Abstract][Full Text] [Related]
4. Illustrative disorders of ectopic skeletal morphogenesis: a childhood parallax for studies in gravitational and space biology.
Kaplan FS; Shore EM
Gravit Space Biol Bull; 1999 May; 12(2):27-38. PubMed ID: 11541780
[TBL] [Abstract][Full Text] [Related]
5. Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis.
Ahn J; Serrano de la Pena L; Shore EM; Kaplan FS
J Bone Joint Surg Am; 2003 Apr; 85(4):667-74. PubMed ID: 12672843
[TBL] [Abstract][Full Text] [Related]
6. Acute lymphocytic infiltration in an extremely early lesion of fibrodysplasia ossificans progressiva.
Gannon FH; Valentine BA; Shore EM; Zasloff MA; Kaplan FS
Clin Orthop Relat Res; 1998 Jan; (346):19-25. PubMed ID: 9577406
[TBL] [Abstract][Full Text] [Related]
7. Characterization of bone morphogenetic protein 4 receptor in fibrodysplasia ossificans progressiva.
Lanchoney TF; Olmsted EA; Shore EM; Gannon FA; Rosen V; Zasloff MA; Kaplan FS
Clin Orthop Relat Res; 1998 Jan; (346):38-45. PubMed ID: 9577408
[TBL] [Abstract][Full Text] [Related]
8. Embryonic overexpression of the c-Fos protooncogene. A murine stem cell chimera applicable to the study of fibrodysplasia ossificans progressiva in humans.
Olmsted EA; Gannon FH; Wang ZQ; Grigoriadis AE; Wagner EF; Zasloff MA; Shore EM; Kaplan FS
Clin Orthop Relat Res; 1998 Jan; (346):81-94. PubMed ID: 9577414
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem-cell contribution to ectopic skeletogenesis.
Kaplan FS; Glaser DL; Shore EM; Pignolo RJ; Xu M; Zhang Y; Senitzer D; Forman SJ; Emerson SG
J Bone Joint Surg Am; 2007 Feb; 89(2):347-57. PubMed ID: 17272450
[TBL] [Abstract][Full Text] [Related]
10. Mutational screening of the bone morphogenetic protein 4 gene in a family with fibrodysplasia ossificans progressiva.
Xu M; Shore EM
Clin Orthop Relat Res; 1998 Jan; (346):53-8. PubMed ID: 9577410
[TBL] [Abstract][Full Text] [Related]
11. [Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva].
Katagiri T; Kamizono J; Nakashima Y; Kitoh H; Susami T; Haga N
Clin Calcium; 2010 Oct; 20(10):1510-7. PubMed ID: 20890033
[TBL] [Abstract][Full Text] [Related]
12. Lumbar puncture and surgical intervention in a child with undiagnosed fibrodysplasia ossificans progressiva.
Zaghloul KA; Heuer GG; Guttenberg MD; Shore EM; Kaplan FS; Storm PB
J Neurosurg Pediatr; 2008 Jan; 1(1):91-4. PubMed ID: 18352811
[TBL] [Abstract][Full Text] [Related]
13. A new mutation of the noggin gene in a French Fibrodysplasia ossificans progressiva (FOP) family.
Fontaine K; Sémonin O; Legarde JP; Lenoir G; Lucotte G
Genet Couns; 2005; 16(2):149-54. PubMed ID: 16080294
[TBL] [Abstract][Full Text] [Related]
14. Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva.
Kitterman JA; Kantanie S; Rocke DM; Kaplan FS
Pediatrics; 2005 Nov; 116(5):e654-61. PubMed ID: 16230464
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic proteins with some comments on fibrodysplasia ossificans progressiva and NOGGIN.
Cohen MM
Am J Med Genet; 2002 Apr; 109(2):87-92. PubMed ID: 11977155
[No Abstract] [Full Text] [Related]
16. Fibrodysplasia ossificans progressiva: diagnosis and surgical management.
Trigui M; Ayadi K; Zribi M; Triki Z; Keskes H
Acta Orthop Belg; 2011 Apr; 77(2):139-44. PubMed ID: 21667723
[TBL] [Abstract][Full Text] [Related]
17. Mast cell involvement in fibrodysplasia ossificans progressiva.
Gannon FH; Glaser D; Caron R; Thompson LD; Shore EM; Kaplan FS
Hum Pathol; 2001 Aug; 32(8):842-8. PubMed ID: 11521229
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of bone and cartilage related genes in fibrodysplasia ossificans progressiva, myositis ossificans traumatica, and osteogenic sarcoma.
Shafritz AB; Kaplan FS
Clin Orthop Relat Res; 1998 Jan; (346):46-52. PubMed ID: 9577409
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype.
Kan L; Hu M; Gomes WA; Kessler JA
Am J Pathol; 2004 Oct; 165(4):1107-15. PubMed ID: 15466378
[TBL] [Abstract][Full Text] [Related]
20. Human leukocyte antigen B27 allele is not correlated with fibrodysplasia ossificans progressiva.
Calvert GT; Shore EM
Clin Orthop Relat Res; 1998 Jan; (346):66-70. PubMed ID: 9577412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
